Invitrogen, ABI, Phoenix S&T, Theranostics Health, Ray Biotech, AnaSpec, Thermo Fisher Scientific, Direvo, Bayer Healthcare | GenomeWeb
Invitrogen, ABI Announce Structure of Post-merger Firm; Lauman to Head MS
 
Invitrogen and Applied Biosystems this week announced the creation of the Mass Spectrometry Systems, one of four divisions that will make up the new company after the merger of the two firms.
 
Laura Lauman, currently the president of ABI’s proteomics and small-molecule division, will head the mass spec division in the new company, which will take on the ABI name.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.